Lifecome Biochemistry Co

Lifecome Biochemistry Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Lifecome Biochemistry Co (002868.SZ) as of Oct 29, 2026 is 111.21 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -3.68 % — a change of -3,125.74% (higher).

FCF Conversion

111.21 %

YoY

-3,125.74%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Lifecome Biochemistry Co is 2025 111.21 % . FCF Conversion Rate (FCF/EBITDA) of Lifecome Biochemistry Co was 2024 -3.68 % . It decreases by -3,125.74% higher compared to the previous year.

The Lifecome Biochemistry Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
46.55 CNY
Jan 1, 2019
-90.43 CNY
Jan 1, 2020
-377.40 CNY
Jan 1, 2021
1,236.36 CNY
Jan 1, 2022
119.86 CNY
Jan 1, 2023
293.62 CNY
Jan 1, 2024
-3.68 CNY
Jan 1, 2025
111.21 CNY
The Lifecome Biochemistry Co FCF Conversion history
YEARFCF ConversionYoY
111.21 %-3,125.74%
-3.68 %-101.25%
293.62 %+144.97%
119.86 %-90.31%
1,236.36 %-427.60%
-377.40 %+317.35%
-90.43 %-294.28%
46.55 %-48.42%
90.25 %-30.88%
130.56 %+16.60%
111.97 %-7.57%
121.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifecome Biochemistry Co Stock analysis

What does Lifecome Biochemistry Co do? Lifecome Biochemistry Co., Ltd. generates revenue through the production and sale of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives, and biological pesticides. The company's product portfolio includes bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series, and Jinggangmycin series. These products are distributed domestically and internationally, targeting agricultural and veterinary sectors for animal health and feed enhancement. The firm's primary customers are domestic agricultural enterprises and international buyers seeking veterinary and feed solutions. Veterinary premixes and raw materials are key revenue drivers, alongside biological pesticides used in farming. Food and feed additives cater to the growing demand for safe and efficient animal nutrition products in both local and global markets. Lifecome Biochemistry's sales strategy focuses on leveraging its range of microbial pharmaceuticals, including probiotics and biological pesticides, to serve the agricultural industry. The company's domestic market presence is complemented by overseas distribution, ensuring a steady revenue stream from both regional and international clients. Lifecome Biochemistry Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifecome Biochemistry Co stock

FCF Conversion Rate (FCF/EBITDA) of Lifecome Biochemistry Co is 111.21 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Lifecome Biochemistry Co changed from -3.68 % to 111.21 %, representing a -3,125.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Lifecome Biochemistry Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Lifecome Biochemistry Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Lifecome Biochemistry Co

All Key Metrics — Lifecome Biochemistry Co